Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

No Thumbnail Available
Authors
Delmas, P. D.
Recker, R. R.
Chesnut, C. H.
Skag, A.
Stakkestad, J. A.
Emkey, R.
Gilbride, J.
Schimmer, R. C.
Christiansen, C.
Issue Date
2004
Type
Journal Article
Language
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Description
Citation
Delmas, PD; Recker, RR; Chesnut, CH; Skag, A.; Stakkestad, JA; Emkey, R.; Gilbride, J.; Schimmer, RC; Christiansen, C. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporosis International. 2004, OCT. 15(10):792-798.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1433-2965
0937-941X
EISSN